The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
121883703 12188370 3 F 2011 20160914 20160317 20160920 EXP BR-ABBVIE-15K-020-1335723-00 ABBVIE 0.00 F Y 79.00000 KG 20160920 CN COUNTRY NOT SPECIFIED BR

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
121883703 12188370 1 PS HUMIRA ADALIMUMAB 1 Subcutaneous Y N 58118XH01,59126X1102 125057 40 MG SOLUTION FOR INJECTION IN PRE-FILLED SYRINGE
121883703 12188370 2 SS HUMIRA ADALIMUMAB 1 Subcutaneous Y N 58118XH01,59126X1102 125057 40 MG SOLUTION FOR INJECTION IN PRE-FILLED SYRINGE
121883703 12188370 3 C CALCIUM CALCIUM 1 Oral 0 TABLET
121883703 12188370 4 C DEPURA CHOLECALCIFEROL 1 0
121883703 12188370 5 C ACTONEL RISEDRONATE SODIUM 1 Oral 0 150 MG TABLET /month
121883703 12188370 6 C ACTONEL RISEDRONATE SODIUM 1 0
121883703 12188370 7 C ACTONEL RISEDRONATE SODIUM 1 0
121883703 12188370 8 C DIOVAN VALSARTAN 1 0
121883703 12188370 9 C HIGROTON CHLORTHALIDONE 1 Oral 0 TABLET
121883703 12188370 10 C TRILEPTAL OXCARBAZEPINE 1 Oral 0 TABLET
121883703 12188370 11 C TRILEPTAL OXCARBAZEPINE 1 0
121883703 12188370 12 C PAMELOR NORTRIPTYLINE HYDROCHLORIDE 1 Oral 0 TABLET
121883703 12188370 13 C PREDNISOLONE. PREDNISOLONE 1 Oral 0 1 DF TABLET
121883703 12188370 14 C EXELON RIVASTIGMINE TARTRATE 1 Oral 0 TABLET
121883703 12188370 15 C DEPURA CHOLECALCIFEROL 1 Oral 0 ORAL DROPS
121883703 12188370 16 C CALTRATE CALCIUM CARBONATE 1 Oral 0 TABLET
121883703 12188370 17 C DEPURA CHOLECALCIFEROL 1 Oral 0 ORAL DROPS

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
121883703 12188370 1 Rheumatoid arthritis
121883703 12188370 3 Bone disorder
121883703 12188370 4 Product used for unknown indication
121883703 12188370 5 Arthritis
121883703 12188370 6 Hormone replacement therapy
121883703 12188370 7 Bone disorder
121883703 12188370 8 Product used for unknown indication
121883703 12188370 9 Diuretic therapy
121883703 12188370 10 Sleep disorder therapy
121883703 12188370 11 Nervous system disorder
121883703 12188370 12 Sleep disorder therapy
121883703 12188370 13 Musculoskeletal stiffness
121883703 12188370 14 Memory impairment
121883703 12188370 15 Vitamin supplementation
121883703 12188370 16 Bone disorder
121883703 12188370 17 Product used for unknown indication

Outcome of event

Event ID CASEID OUTC COD
121883703 12188370 OT

Reactions reported

Event ID CASEID DRUG REC ACT PT
121883703 12188370 Arthralgia
121883703 12188370 Bone decalcification
121883703 12188370 Fall
121883703 12188370 Fracture pain
121883703 12188370 Headache
121883703 12188370 Hypovitaminosis
121883703 12188370 Memory impairment
121883703 12188370 Rib fracture
121883703 12188370 Sensitivity to weather change
121883703 12188370 Spinal fracture

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID CASEID DSG DRUG SEQ START DT END DT DUR DUR COD
121883703 12188370 1 20110102 0
121883703 12188370 9 2013 0
121883703 12188370 10 2010 0
121883703 12188370 12 2010 0
121883703 12188370 14 2010 0
121883703 12188370 15 2011 0